The Cardioprotective Effect of the Hydroalcoholic Extract of Ginger in Renovascular Hypertension Model in Male Rats
Abstract
Background and Aim: Many studies have been conducted worldwide to control blood pressure through herbal medicines. The present study was conducted to investigate ginger's role in the treatment of hypertension. Materials and Methods: Fifty-four male Wistar rats weighing about 200 to 250 grams were randomly divided into 6 groups (3 groups of ten, and 3 groups of eight rats) for in vivo investigation. The left renal artery was blocked using a non-allergenic stainless-steel clamp to create hypertension. Then, the hydroalcoholic extract of ginger was prepared using distilled water in three doses of 100, 200, and 300 mg/kg. Oral gavage administration was used for the rats daily for 42 days using the hydroalcoholic extract of ginger. Pulmonary blood pressure was assessed using a cuff sphygmomanometer. Electrocardiogram (EKG or ECG) and echocardiogram (echo) tests were also performed after the end of the gavage on the 42nd day. Moreover, the amount of nitric oxide (NO) in serum samples was measured using the Griess reagent system. After categorizing raw data in Excel, they were analyzed using analysis of variance (ANOVA) by SPSS software. Results: In this study, it was observed that ginger could notably decrease blood pressure. This decrease in blood pressure is due to the diuretic effect of the ginger's extract. Consequently, the use of ginger decreases the amount of NO. Furthermore, these data revealed that ginger had no toxic effect on the heart, and using this plant in hypertensive heart disease patients is safe. Conclusion: Considering the positive effects of ginger in decreasing blood pressure and its non-toxicity for the heart, it is recommended to conduct further specialized studies and clinical trials in this regard.References
Ibrahim MM, Damasceno A. Hypertension in developing countries. Lancet. 2012;380(9841):611-9.
Whelton PK. Epidemiology of hypertension. Lancet. 1994;344(8915):101-6.
Sliwa K, Stewart S, Gersh BJ. Hypertension: a global perspective. Circulation. 2011;123(24):2892-6.
Ogedegbe G. Barriers to optimal hypertension control. Journal of Clinical Hypertension. 2008;10(8):644-6.
Staessen JA, Wang J, Bianchi G, Birkenhäger WH. Essential hypertension. Lancet. 2003;361(9369):1629-41.
Planas LG, Crosby KM, Mitchell KD, Farmer KC. Evaluation of a hypertension medication therapy management program in patients with diabetes. Journal of American Pharmacists Association. 2009;49(2):164-70.
Boutari C, Georgianou E, Sachinidis A, Katsimardou A, Christou K, Piperidou A, et al. Renovascular hypertension: novel insights. Current hypertension reviews. 2020;16(1):24-9.
Martinez-Maldonado M. Pathophysiology of renovascular hypertension. Hypertension. 1991;17(5):707-19.
Stanley JC. Surgical treatment of renovascular hypertension. The American Journal of Surgery. 1997;174(2):102-10.
Organization WH. WHO monographs on selected medicinal plants: World Health Organization; 1999.
Stoilova I, Krastanov A, Stoyanova A, Denev P, Gargova S. Antioxidant activity of a ginger extract (Zingiber officinale). Food chemistry. 2007;102(3):764-70.
Shaban MI, EL-Gahsh NFA, El-said A, El-sol H. Ginger: It's Effect on Blood Pressure among Hypertensive Patients. IOSR-JNHS. 2017;6(5):79-86.
Schuetze S, Manig A, Ribes S, Nau R. Aged mice show an increased mortality after anesthesia with a standard dose of ketamine/xylazine. Laboratory animal research. 2019;25(8).
Katrina M. Miranda 1, Michael G. Espey, David A. Wink. A Rapid, Simple Spectrophotometric Method for Simultaneous Detection of Nitrate and Nitrite. 2001;5(1).
Hanifah N, Achmad YF, Humaira A, Salasia SIO. Red ginger-extract nanoemulsion modulates high blood pressure in rats by regulating angiotensin-converting enzyme production. Veterinary World. 2021;14(1):176.
Ghayur MN, Gilani AH. Ginger lowers blood pressure through blockade of voltage-dependent calcium channels. Journal of cardiovascular pharmacology. 2005;45(1):74-80.
Azimi P, Ghiasvand R, Feizi A, Hosseinzadeh J, Bahreynian M, Hariri M, et al. Effect of cinnamon, cardamom, saffron and ginger consumption on blood pressure and a marker of endothelial function in patients with type 2 diabetes mellitus: A randomized controlled clinical trial. Blood pressure. 2016;25(3):133-40.
Ferrini MG, Garcia E, Abraham A, Artaza JN, Nguyen S, Rajfer J. Effect of ginger, Paullinia cupana, muira puama and l-citrulline, singly or in combination, on modulation of the inducible nitric oxide-NO-cGMP pathway in rat penile smooth muscle cells. nitric oxide. 2018;76:81-6.
18. Balamuthusamy S, Kannan A, Thajudeen B, Ottley D, Jalandhara N. Mild Renal Artery Stenosis Can Induce Renovascular Hypertension and is Associated with Elevated Renal Vein Renin Secretion. 2015;28(3):293-8.
Fakhri S, Patra J, Das S, Das G, Majnooni M, Farzaei M. Ginger and Heart Health: From Mechanisms to Therapeutics. 2021;14(6):943-59.
Ebrahimzadeh A, Ebrahimzadeh A, Mirghazanfari M, Hazrati E, Hadi S, Milajerdi A. The effect of ginger supplementation on metabolic profiles in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials. 2022;65.
Salih A, Alwan A, Khadim M, Haleem Al-qaim Z, Mardanov B, Amr A, et al. Effect of ginger (Zingiber officinale) intake on human serum lipid profile: Systematic review and meta-analysis. 2023.
Ghayur M, Gilani A, Afridi M, Peter J. Cardiovascular effects of ginger aqueous extract and its phenolic constituents are mediated through multiple pathways. 2005;43(4):234-41.
Akinyemi A, Ademiluyi A, Oboh G. Inhibition of angiotensin-1-converting enzyme activity by two varieties of ginger (Zingiber officinale) in rats fed a high cholesterol diet. J Med Food. 2014;17(3):317-23.
Qian-Qian M, Xiao-Yu X, Shi-Yu C, Ren-You G, et al. Bioactive Compounds and Bioactivities of Ginger (Zingiber officinale Roscoe). Foods. 2019;8(6):185.
Li C, Li J, Jiang F, Tzvetkov T, Horbanczuk J, Li Y et al. Vasculoprotective effects of ginger (Zingiber officinale Roscoe) and underlying molecular mechanisms. Food & Function. 2021;12:1897-913.
Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation. Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. This work is licensed under a Creative Commons license (CC-BY). However, the license permits any user to read, copy, redistribute and and make derivative the material in any medium or format for any purpose, even commercially.